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Ubiquitin superfolds: intrinsic and attachable regulators of
cellular activities?
R John Mayer, Michael Landon and Robert Layfield
Ubiquitinylation, the post-translational covalent
conjugation of ubiquitin to other proteins, mediates
diverse cellular processes in addition to the
proteasome-catalysed degradation signalled by
multiple ubiquitinylation. Ubiquitin superfolds have also
been found in other proteins. The amino acid sequences
of these superfolds are unrelated to ubiquitin, but they
have an almost identical three-dimensional shape to
that of ubiquitin. Additionally, a number of ‘ubiquitin-
like’ proteins, some of which can be conjugated to other
proteins, may also contain the ubiquitin superfold.
Intrinsic and attachable ubiquitin superfolds can act as
powerful ligands and probably have important roles in
protein–protein interactions in the cell.
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The range of ubiquitin-related built-in and attachable units
Ubiquitinylation is a major post-translational modification
of cellular proteins. Proteins destined for degradation by
the 26S proteasome, for example, are multiply ubiquitiny-
lated on one or more lysine residues [1–3]. Crystallo-
graphic analyses have revealed a single ‘ubiquitin
superfold’ with hardly any sequence resemblance to ubiq-
uitin but with an almost identical three-dimensional shape
in protein G [4] and also in the Ras-binding domain of Raf
kinase [5]. The ubiquitin superfold is one of at least nine
folds known to occur in proteins having neither sequence
or functional similarity [6]. Indeed, other signalling pro-
teins are also known to be either mono-ubiquitinylated
(for example the epidermal growth factor receptor pathway
substrate Eps [7]) or transiently multi-ubiquitinylated (for
example the colony-stimulating factor receptor-linked c-
Cbl [8]) following ligand–receptor interactions. In these
cases, however, ubiquitinylation does not signal protea-
some-catalysed degradation. The ubiquitin superfold may
therefore occur either intrinsically in natural gene prod-
ucts, such as Raf kinase and presumably ubiquitin–riboso-
mal protein fusions [9], or be transiently attached. An
intrinsic or mobile ubiquitin superfold should act as a pow-
erful ligand for protein–protein interactions in the cell.
In addition to the fused or mobile ubiquitin superfold, a
number of fused or mobile ubiquitin-like proteins have
arisen in the course of evolution [10] (Figure 1). Ubiqui-
tin-like sequences are found in many fusion proteins
involved in processes such as transcriptional elongation
[11], spliceosome function [12], spindle pole body dupli-
cation [13] and nucleotide-excision repair [14]. In the last
case, the ubiquitin-like domain of Rad23 can be function-
ally replaced by a ubiquitin sequence [15] and has
recently been shown to interact with the 26S proteasome
[16]. These observations indicate a functional significance
for the ubiquitin-like domain. The mobile ubiquitin cross-
reactive protein (UCRP), which is inducible by inter-
feron-γ, is di-ubiquitin-like [17], is found conjugated to
proteins [18] and is widespread in human tissues [19].
Additionally, a small ubiquitin-related modifier (SUMO-1)
is conjugated to a GTPase-activating protein (Ran-GAP)
to control the nuclear import of proteins [20]. This protein
(also called sentrin) is involved in protecting cells against
apoptosis induced by Fas/APO-1 or the tumour necrosis
factor receptor [21].
Ubiquitin-like domains are predicted to be structurally
conserved [10]. This notion is confirmed by the recent
demonstration, using NMR, that the overall structure of
SUMO-1 closely resembles that of ubiquitin, although
SUMO-1 additionally has a long and flexible amino termi-
nus that is absent in ubiquitin. The hydrophobic cores of
SUMO-1 and ubiquitin are maintained but the overall
charge topologies of the proteins differ significantly, which
may indicate different interaction partners for these pro-
teins [22]. It is likely that a number of ubiquitin-like mole-
cules will be conformationally sufficiently unlike ubiquitin
and each other to participate in a large number of specific
protein–protein interactions of regulatory significance.
The surface potential of the ubiquitin superfold in Raf
kinase is again dissimilar to the surface potential of ubiqui-
tin (Carlo Petosa, personal communication) and it is likely
that a variety of surface-charge profiles can be built onto
the ubiquitin-like superfold scaffolds. Integral ubiquitin or
ubiquitin-like superfolds (collectively defined as ‘ubiqui-
tons’) or the transient attachment of mobile ubiquitons can
provide a protein with a unique informationally-rich motif
by which to interact with other proteins in the cell.
Ubiquitons are everywhere!
Ubiquitons are even involved in extracellular processes.
The Fau oncogene product is a fusion of a ubiquiton and a
ribosomal protein subunit (S30). Recently, a protein that is
almost identical to Fau has been identified as a secreted
lymphokine. This is the monoclonal non-specific suppres-
sor factor β (MNSFβ), which is a non-specific negative
regulator of the immune system [23]. It is the ubiquiton
and not the S30 moiety of the fusion protein that has the
immune-suppressing activity [24]. Like the UCRP gene,
the expression of the MNSFβ fusion gene is stimulated by
interferon-γ. The Fau ubiquiton–S30 ribosomal subunit
fusion occurs in higher eukaryotes (nematodes and
mammals) but not in lower eukaryotes (yeast, plants and
protists), where S30 occurs alone [25]. This ubiquiton pre-
sumably arose, then, after the divergence of yeast and
nematodes. Nematodes (and other parasites) would gain a
selective advantage from producing the secreted ubiqui-
ton–S30 fusion protein and thereby suppressing the
immune system of infected hosts.
Mobile ubiquitons and phosphates: major regulators of
cell signalling?
The transient attachment of ubiquitons to proteins pro-
vides an opportunity for regulatory interactions to match
and extend those consequent upon protein phosphoryla-
tion. A close interplay between tyrosine phosphorylation
and ubiquitinylation is already clear, for example in post-
translational modifications of Eps and c-Cbl in response to
receptor–ligand interactions [7,8]. There is also coordina-
tion between phosphorylation and ubiquitinylation in the
preparation of the cytoplasmic protein IκB for degradation
by the 26S proteasome [26]. This theme is extended to
the process of ubiquitinylation itself: in yeast, the ubiqui-
ton RUB1 is conjugated to an SCF ubiquitin protein
ligase — a newly identified family of E3 ligases in which
target specificity is built into a hetero-oligomeric complex
by the F-box subunits — and may have a regulatory role
in the ubiquitinylation of phosphorylated protein targets
such as cell-cycle regulators [27,28].
The usefulness of ubiquitin superfolds for protein–protein
interactions may have been the evolutionary platform (the
ubiquitin superfold should exist in prokaryotes) for the
utilisation of ubiquitin and multi-ubiquitinylation as a
signal for protein degradation by the 26S proteasome. In
addition to covalently attached mobile and built-in ubiq-
uitons, some proteins non-covalently interact with free
ubiquitin (for example p62, a phosphotyrosine-indepen-
dent SH2 ligand [29]) or with the ubiquitin-like protein
UBL1 (for example the human DNA-repair proteins
Rad51 and Rad52 [30]). Some proteins, for example some
protein kinases, contain a ‘ubiquitin-associated’ (UBA)
domain that may confer target specificity for multiple
enzymes of the ubiquitinylation/de-ubiquitinylation
systems [31].
Finally, there are numerous de-ubiquitinylating enzymes
(there are 17 in yeast [2]) that presumably have key roles
in physiological processes. These enzymes are important
in normal development [32] and cell-cycle progression
[33] and at least two of them — Tre-2 [34] and Unp
[35] — are oncogenic if inappropriately expressed.
De-ubiquitinylation, like dephosphorylation, has a central
role in the life process.
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Figure 1
Schematic representation of attachable and
intrinsic ‘ubiquitons’. (a) The attachment of
ubiquitin moieties to proteins such as Eps and
c-Cbl is not connected with protein turnover,
but instead mediates cell signalling.
(b) Intrinsic ubiquitin superfolds, found in
proteins such as protein G and Raf,
presumably act as ligands for protein–protein
interactions. (c) Ubiquitin-like proteins, such
as UCRP and SUMO-1, are also conjugated
to other proteins; the conjugation of SUMO-1
to Ran-GAP, for example, controls the nuclear
import of proteins. (d) Intrinsic ubiquitin-like
superfolds (of unknown three-dimensional
shapes) are also found in proteins such as
Rad23, Fau and MNSFβ; as for intrinsic
ubiquitin superfolds, these domains
presumably act as ligands for protein–protein
interactions.
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